Medical Technology and Devices Portfolio
Fund
FSMEX
Price as of:
$43.98
- $0.18
- 0.41%
Primary Theme
fund company
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
-22.9%
1 yr return
-18.8%
3 Yr Avg Return
-5.0%
5 Yr Avg Return
-4.2%
Net Assets
$3.02 B
Holdings in Top 10
67.3%
52 WEEK LOW AND HIGH
$44.2
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 0.62%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 32.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 06/01/2026Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
FSMEX - Profile
Distributions
- YTD Total Return -22.9%
- 3 Yr Annualized Total Return -5.0%
- 5 Yr Annualized Total Return -4.2%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio -0.46%
- Dividend Yield 0.0%
- Dividend Distribution Frequency SemiAnnual
Fund Details
-
Legal NameMedical Technology and Devices Portfolio
-
Fund Family NameFidelity Investments
-
Inception DateJun 30, 1998
-
Shares OutstandingN/A
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerEdward Yoon
Fund Description
Normally investing at least 80% of assets in securities of companies principally engaged in research, development, manufacture, distribution, supply, or sale of medical equipment and devices and related technologies, companies enabling drug discovery, and companies providing information technology services primarily to health care providers. These companies may include, for example, manufacturers of health care equipment and supplies including drug delivery systems and eye care products, firms providing services directly related to the pharmaceutical and biotechnology industries, and companies providing applications, systems and/or data processing software, and IT consulting services and tools to doctors, hospitals, and health care businesses. For purposes of the fund's policy to normally invest at least 80% of its assets in securities of companies principally engaged in the business activity or activities identified for the fund, Fidelity may consider a company to be principally engaged in the designated business activity or activities based on: (i) the level of a company's assets, income, sales, or profits that are committed to, derived from, or related to the designated business activity or activities, or (ii) whether a third party has given the company an industry or sector classification consistent with the designated business activity or activities. Whether a company is principally engaged in the designated business activity or activities can be determined under any of these factors. Derivative instruments that provide investment exposure to the investments above or exposure to one or more market risk factors associated with such investments are included in the fund's 80% policy, consistent with the fund's investment policies and limitations with respect to investments in derivatives. Normally investing primarily in common stocks. Investing in domestic and foreign issuers. Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
Read More
FSMEX - Performance
Return Ranking - Trailing
| Period | FSMEX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -22.9% | -22.9% | 20.0% | 100.00% |
| 1 Yr | -18.8% | -20.4% | 134.5% | 99.38% |
| 3 Yr | -5.0%* | -6.3% | 23.9% | 99.38% |
| 5 Yr | -4.2%* | -15.5% | 12.3% | 95.48% |
| 10 Yr | 8.0%* | 3.0% | 13.1% | 52.76% |
* Annualized
Return Ranking - Calendar
| Period | FSMEX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | -3.1% | -21.9% | 61.0% | 96.25% |
| 2024 | 0.4% | -28.2% | 19.2% | 31.25% |
| 2023 | 0.6% | -8.6% | 19.0% | 66.25% |
| 2022 | -26.0% | -53.9% | 3.2% | 92.90% |
| 2021 | 14.2% | -39.6% | 24.2% | 10.32% |
Total Return Ranking - Trailing
| Period | FSMEX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -22.9% | -22.9% | 20.0% | 100.00% |
| 1 Yr | -18.8% | -20.4% | 134.5% | 99.38% |
| 3 Yr | -5.0%* | -6.3% | 23.9% | 99.38% |
| 5 Yr | -4.2%* | -15.5% | 12.3% | 95.48% |
| 10 Yr | 8.0%* | 3.0% | 13.1% | 52.76% |
* Annualized
Total Return Ranking - Calendar
| Period | FSMEX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2025 | 4.8% | -0.5% | 63.7% | 96.88% |
| 2024 | 9.9% | -28.2% | 19.2% | 4.38% |
| 2023 | 0.6% | -8.6% | 19.0% | 88.13% |
| 2022 | -24.8% | -53.9% | 3.7% | 93.55% |
| 2021 | 24.5% | -33.9% | 26.0% | 2.58% |
NAV & Total Return History
FSMEX - Holdings
Concentration Analysis
| FSMEX | Category Low | Category High | FSMEX % Rank | |
|---|---|---|---|---|
| Net Assets | 3.02 B | 6.38 M | 37.9 B | 16.88% |
| Number of Holdings | 66 | 24 | 416 | 63.75% |
| Net Assets in Top 10 | 2.46 B | 3.49 M | 22.8 B | 10.63% |
| Weighting of Top 10 | 67.35% | 16.2% | 79.4% | 5.00% |
Top 10 Holdings
- DANAHER CORP 13.62%
- BOSTON SCIENTIFIC CORP 12.32%
- THERMO FISHER SCIENTIFIC INC 9.57%
- INTUITIVE SURGICAL INC 8.69%
- EDWARDS LIFESCIENCES CORP 5.59%
- STRYKER CORP 4.94%
- ABBOTT LABORATORIES 4.88%
- MASIMO CORP 2.69%
- VEEVA SYS INC CL A 2.63%
- INSULET CORP 2.43%
Asset Allocation
| Weighting | Return Low | Return High | FSMEX % Rank | |
|---|---|---|---|---|
| Stocks | 95.71% | 88.27% | 106.13% | 71.25% |
| Preferred Stocks | 2.43% | 0.00% | 7.86% | 13.75% |
| Cash | 1.82% | 0.00% | 32.31% | 45.63% |
| Bonds | 0.05% | 0.00% | 12.39% | 15.00% |
| Other | 0.00% | -22.99% | 4.13% | 45.63% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 29.68% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | FSMEX % Rank | |
|---|---|---|---|---|
| Healthcare | 96.50% | 59.26% | 100.00% | 90.97% |
| Basic Materials | 2.87% | 0.00% | 7.16% | 5.16% |
| Consumer Defense | 0.63% | 0.00% | 25.73% | 3.87% |
| Utilities | 0.00% | 0.00% | 0.00% | 22.58% |
| Technology | 0.00% | 0.00% | 22.69% | 27.74% |
| Real Estate | 0.00% | 0.00% | 5.89% | 27.74% |
| Industrials | 0.00% | 0.00% | 7.02% | 27.74% |
| Financial Services | 0.00% | 0.00% | 1.60% | 43.23% |
| Energy | 0.00% | 0.00% | 0.00% | 22.58% |
| Communication Services | 0.00% | 0.00% | 9.11% | 25.81% |
| Consumer Cyclical | 0.00% | 0.00% | 1.92% | 27.74% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | FSMEX % Rank | |
|---|---|---|---|---|
| US | 94.06% | 60.50% | 104.41% | 51.88% |
| Non US | 1.64% | 0.00% | 36.86% | 60.00% |
Bond Sector Breakdown
| Weighting | Return Low | Return High | FSMEX % Rank | |
|---|---|---|---|---|
| Cash & Equivalents | 1.54% | 0.00% | 100.00% | 43.75% |
| Derivative | 0.00% | -0.01% | 0.21% | 33.13% |
| Securitized | 0.00% | 0.00% | 0.00% | 24.46% |
| Corporate | 0.00% | 0.00% | 81.57% | 43.17% |
| Municipal | 0.00% | 0.00% | 0.00% | 24.46% |
| Government | 0.00% | 0.00% | 29.44% | 25.90% |
Bond Geographic Breakdown
| Weighting | Return Low | Return High | FSMEX % Rank | |
|---|---|---|---|---|
| US | 0.05% | 0.00% | 11.75% | 15.00% |
| Non US | 0.00% | 0.00% | 3.33% | 24.38% |
FSMEX - Expenses
Operational Fees
| FSMEX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.62% | 0.08% | 4.69% | 80.00% |
| Management Fee | 0.61% | 0.03% | 1.25% | 25.63% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| FSMEX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
| FSMEX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 1.00% | 75.61% |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| FSMEX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 32.00% | 1.00% | 238.00% | 24.64% |
FSMEX - Distributions
Dividend Yield Analysis
| FSMEX | Category Low | Category High | FSMEX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 6.24% | 50.63% |
Dividend Distribution Analysis
| FSMEX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | SemiAnnual | Annual | Annual | Annual |
Net Income Ratio Analysis
| FSMEX | Category Low | Category High | FSMEX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.46% | -2.54% | 1.85% | 66.01% |
Capital Gain Distribution Analysis
| FSMEX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Semi-Annually | Annually | Semi-Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Apr 10, 2026 | $6.542 | CapitalGainLongTerm |
| Dec 12, 2025 | $2.990 | CapitalGainLongTerm |
| Apr 11, 2025 | $1.678 | CapitalGainLongTerm |
| Dec 13, 2024 | $4.640 | CapitalGainLongTerm |
| Apr 12, 2024 | $1.315 | CapitalGainLongTerm |
| Apr 08, 2022 | $1.109 | CapitalGainLongTerm |
| Dec 17, 2021 | $3.124 | CapitalGainLongTerm |
| Apr 09, 2021 | $3.633 | OrdinaryDividend |
| Dec 18, 2020 | $3.541 | OrdinaryDividend |
| Apr 08, 2020 | $1.299 | CapitalGainLongTerm |
| Dec 20, 2019 | $1.064 | CapitalGainLongTerm |
| Dec 14, 2018 | $1.612 | CapitalGainLongTerm |
| Apr 06, 2018 | $1.919 | CapitalGainLongTerm |
| Dec 15, 2017 | $0.080 | OrdinaryDividend |
| Dec 15, 2017 | $2.467 | CapitalGainLongTerm |
| Apr 07, 2017 | $0.199 | CapitalGainLongTerm |
| Dec 16, 2016 | $0.420 | CapitalGainShortTerm |
| Dec 16, 2016 | $1.435 | CapitalGainLongTerm |
| Apr 08, 2016 | $0.295 | CapitalGainLongTerm |
| Dec 18, 2015 | $0.006 | OrdinaryDividend |
| Dec 18, 2015 | $0.366 | CapitalGainShortTerm |
| Dec 18, 2015 | $1.298 | CapitalGainLongTerm |
| Apr 13, 2015 | $0.980 | CapitalGainShortTerm |
| Apr 13, 2015 | $3.216 | CapitalGainLongTerm |
| Dec 22, 2014 | $0.048 | OrdinaryDividend |
| Dec 22, 2014 | $0.823 | CapitalGainShortTerm |
| Dec 22, 2014 | $3.203 | CapitalGainLongTerm |
| Apr 14, 2014 | $0.765 | CapitalGainShortTerm |
| Apr 14, 2014 | $1.193 | CapitalGainLongTerm |
| Dec 23, 2013 | $0.479 | CapitalGainShortTerm |
| Dec 23, 2013 | $2.620 | CapitalGainLongTerm |
| Apr 15, 2013 | $0.076 | CapitalGainShortTerm |
| Apr 15, 2013 | $0.342 | CapitalGainLongTerm |
| Dec 26, 2012 | $0.048 | OrdinaryDividend |
| Dec 26, 2012 | $0.634 | CapitalGainLongTerm |
| Apr 16, 2012 | $0.544 | CapitalGainLongTerm |
| Dec 12, 2011 | $0.015 | OrdinaryDividend |
| Dec 12, 2011 | $1.260 | CapitalGainLongTerm |
| Apr 07, 2011 | $0.166 | CapitalGainLongTerm |
| Dec 15, 2008 | $0.005 | OrdinaryDividend |
| Apr 14, 2008 | $0.230 | CapitalGainShortTerm |
| Apr 14, 2008 | $0.540 | CapitalGainLongTerm |
| Dec 17, 2007 | $0.700 | CapitalGainShortTerm |
| Dec 17, 2007 | $0.840 | CapitalGainLongTerm |
| Apr 16, 2007 | $0.640 | CapitalGainLongTerm |
| Dec 11, 2006 | $1.260 | CapitalGainLongTerm |
| Apr 10, 2006 | $0.990 | CapitalGainLongTerm |
| Dec 12, 2005 | $0.840 | CapitalGainLongTerm |
| Apr 12, 2004 | $0.110 | CapitalGainShortTerm |
| Dec 05, 2003 | $0.320 | CapitalGainShortTerm |
| Dec 05, 2003 | $0.210 | CapitalGainLongTerm |
| Apr 06, 2002 | $0.110 | CapitalGainLongTerm |
| Apr 09, 2001 | $0.130 | CapitalGainShortTerm |
| Apr 09, 2001 | $0.210 | CapitalGainLongTerm |
| Dec 11, 2000 | $0.440 | CapitalGainShortTerm |
| Dec 11, 2000 | $0.240 | CapitalGainLongTerm |
| Apr 10, 2000 | $1.200 | CapitalGainShortTerm |
| Apr 10, 2000 | $0.430 | CapitalGainLongTerm |
| Dec 06, 1999 | $0.060 | CapitalGainLongTerm |
| Apr 05, 1999 | $0.360 | CapitalGainShortTerm |
FSMEX - Fund Manager Analysis
Managers
Edward Yoon
Start Date
Tenure
Tenure Rank
May 01, 2007
15.09
15.1%
Edward (Eddie) Yoon is a sector leader and portfolio manager in the Equity division at Fidelity Investments. Fidelity Investments is a leading provider of investment management, retirement planning, portfolio guidance, brokerage, benefits outsourcing, and other financial products and services to institutions, financial intermediaries, and individuals. In this role, Mr. Yoon is responsible for the coverage of health care equipment and supplies stocks, and serves as the health care sector leader. Additionally, he manages several funds including Fidelity Advisor Health Care Fund, Fidelity and Fidelity Advisor Stock Selector Mid Cap Fund, Fidelity and Fidelity Advisor All Cap Fund, Fidelity Select Health Care Portfolio, and Fidelity Select Medical Technology and Devices Portfolio. Prior to joining Fidelity in 2006, Mr. Yoon worked on the health care team at JPMorgan Asset Management. He has been in the financial industry since 2002. Mr. Yoon earned his bachelor of arts degree in business economics from Brown University.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 8.08 | 0.25 |